Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Venous and Arterial Thrombosis in Ambulatory and Discharged COVID-19 Patients: A Systematic Review and Meta-analysis
Eman M. Mansory, Mohammed Abu-Farhaneh, Alla Iansavitchene, et al.
TH Open (2022) Vol. 06, Iss. 03, pp. e276-e282
Open Access | Times Cited: 11

Showing 11 citing articles:

Rivaroxaban to prevent major clinical outcomes in non-hospitalised patients with COVID-19: the CARE – COALITION VIII randomised clinical trial
Álvaro Avezum, Haliton Alves de Oliveira, Precil Diego Miranda de Menezes Neves, et al.
EClinicalMedicine (2023) Vol. 60, pp. 102004-102004
Open Access | Times Cited: 11
Epidemiology and Predisposing Factors of Post-COVID Venous Thrombosis: A Concise Review
Giuseppe Lippi, Emmanuel J. Favaloro
Seminars in Thrombosis and Hemostasis (2023) Vol. 50, Iss. 02, pp. 271-274
Closed Access | Times Cited: 9
Risk Factors for Postdischarge Major Thromboembolism and Mortality in Hospitalized Patients with COVID-19 with Cardiovascular Comorbidities: Insights from the CORE-19 Registry
Dimitrios Giannis, Mark Goldin, Husneara Rahman, et al.
Thrombosis and Haemostasis (2023) Vol. 123, Iss. 11, pp. 1089-1099
Closed Access | Times Cited: 7
A systematic review on post-discharge venous thromboembolism prophylaxis in patients with COVID-19
Reza Amani‐Beni, Mohammad Kermani‐Alghoraishi, Bahar Darouei, et al.
The Egyptian Heart Journal (2023) Vol. 75, Iss. 1
Open Access | Times Cited: 2
High-risk subgroups were not identified to benefit from thromboprophylaxis after hospitalization for COVID-19
Lisa Baumann Kreuziger, Taeim Kwon, Raj S. Kasthuri, et al.
Research and Practice in Thrombosis and Haemostasis (2024) Vol. 8, Iss. 4, pp. 102417-102417
Open Access
The thromboembolic effect of COVID-19
Giuseppe Lippi, Brandon Michael Henry
Elsevier eBooks (2024), pp. 121-128
Closed Access
Thrombosis and coagulopathy in COVID-19: A current narrative
Alejandro Lazo‐Langner, Mateo Porres‐Aguilar
Elsevier eBooks (2024), pp. 337-348
Closed Access
Prothrombotic state and thrombotic events in COVID-19 pandemic period, including portal vein and splenic artery thromboses
Özgür Karcıoğlu, Canan Akman, G. Öztürk
World Journal of Clinical Cases (2024) Vol. 12, Iss. 33, pp. 6595-6603
Closed Access
Prophylactic-dose direct oral anticoagulants for non-hospitalised people with COVID-19: A meta-analysis of randomised controlled trials
Qingchun Song, Hongduan Liu, Haoyu Tan, et al.
Journal of Global Health (2024) Vol. 14
Open Access
Asymptomatic Esophageal Necrosis in a Patient with Recent COVID-19: The First Case Diagnosed through Autopsy
Ionuț Isaia Jeican, Patricia Inișca, Bogdan‐Alexandru Gheban, et al.
Medicina (2023) Vol. 59, Iss. 1, pp. 154-154
Open Access | Times Cited: 1
Rivaroxaban to Prevent Major Clinical Outcomes in Non-Hospitalised Patients with COVID-19: The Care – Coalition VIII Randomised Clinical Trial
Álvaro Avezum, Haliton Alves de Oliveira, Precil Diego Miranda de Menez Neves, et al.
(2023)
Open Access | Times Cited: 1
Page 1

Scroll to top